Michael B Piansky, MD | |
6043 Prestley Mill Rd Ste B, Douglasville, GA 30134-2280 | |
(770) 941-8100 | |
(678) 945-9331 |
Full Name | Michael B Piansky |
---|---|
Gender | Male |
Speciality | Internal Medicine |
Experience | 32 Years |
Location | 6043 Prestley Mill Rd Ste B, Douglasville, Georgia |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1023087491 | NPI | - | NPPES |
000677443E | Medicaid | GA | |
000677443D | Medicaid | GA | |
110212504 | Other | GA | RAILROAD MEDICARE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | 040196 (Georgia) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Wellstar Home Health, Llc | Marietta, GA | Home health agency |
Central Home Health Care, An Amedisys Company | Douglasville, GA | Home health agency |
Interim Healthcare Of Atlanta Inc | Atlanta, GA | Home health agency |
Wellstar Douglas Hospital | Douglasville, GA | Hospital |
Wellstar Cobb Hospital | Austell, GA | Hospital |
Wellstar Paulding Hospital | Hiram, GA | Hospital |
Wellstar Kennestone Hospital | Marietta, GA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Wellstar Medical Group, Llc | 6709065402 | 1839 |
News Archive
"I am pleased to share with you a new report and video series from the CSIS Global Health Policy Center, 'Global Health Policy in the Second Obama Term,'" J. Stephen Morrison, senior vice president of the Center for Strategic & International Studies (CSIS) and director of the CSIS Global Health Policy Center, writes in a letter posted on the center's "Smart Global Health" blog.
ACADIA Pharmaceuticals Inc., a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, today announced that it has initiated a Phase II feasibility trial designed to examine the efficacy and safety of pimavanserin as a treatment for patients with Alzheimer's disease psychosis.
The Mount Sinai Medical Center is the first medical center in New York City to offer the newly FDA approved HeartMate II® Pocket Controller™ to help its advanced heart failure patients maintain more active lifestyles.
A University of Michigan study suggests that women, but not men, automatically associate sex with submission and that connection reduces the quality of their sexual experience.
A single dose of an investigational anti-inflammatory drug called inclacumab considerably reduces damage to heart muscle during angioplasty (the opening of a blocked artery), according to a recent international clinical trial spearheaded by Dr. Jean-Claude Tardif, Director of the Research Centre at the Montreal Heart Institute, affiliated with the University of Montreal.
› Verified 3 days ago
Entity Name | Wellstar Medical Group, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1558664003 PECOS PAC ID: 6709065402 Enrollment ID: O20110127000374 |
News Archive
"I am pleased to share with you a new report and video series from the CSIS Global Health Policy Center, 'Global Health Policy in the Second Obama Term,'" J. Stephen Morrison, senior vice president of the Center for Strategic & International Studies (CSIS) and director of the CSIS Global Health Policy Center, writes in a letter posted on the center's "Smart Global Health" blog.
ACADIA Pharmaceuticals Inc., a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, today announced that it has initiated a Phase II feasibility trial designed to examine the efficacy and safety of pimavanserin as a treatment for patients with Alzheimer's disease psychosis.
The Mount Sinai Medical Center is the first medical center in New York City to offer the newly FDA approved HeartMate II® Pocket Controller™ to help its advanced heart failure patients maintain more active lifestyles.
A University of Michigan study suggests that women, but not men, automatically associate sex with submission and that connection reduces the quality of their sexual experience.
A single dose of an investigational anti-inflammatory drug called inclacumab considerably reduces damage to heart muscle during angioplasty (the opening of a blocked artery), according to a recent international clinical trial spearheaded by Dr. Jean-Claude Tardif, Director of the Research Centre at the Montreal Heart Institute, affiliated with the University of Montreal.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Michael B Piansky, MD 6043 Prestley Mill Rd Ste B, Douglasville, GA 30134-2280 Ph: (770) 941-8100 | Michael B Piansky, MD 6043 Prestley Mill Rd Ste B, Douglasville, GA 30134-2280 Ph: (770) 941-8100 |
News Archive
"I am pleased to share with you a new report and video series from the CSIS Global Health Policy Center, 'Global Health Policy in the Second Obama Term,'" J. Stephen Morrison, senior vice president of the Center for Strategic & International Studies (CSIS) and director of the CSIS Global Health Policy Center, writes in a letter posted on the center's "Smart Global Health" blog.
ACADIA Pharmaceuticals Inc., a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, today announced that it has initiated a Phase II feasibility trial designed to examine the efficacy and safety of pimavanserin as a treatment for patients with Alzheimer's disease psychosis.
The Mount Sinai Medical Center is the first medical center in New York City to offer the newly FDA approved HeartMate II® Pocket Controller™ to help its advanced heart failure patients maintain more active lifestyles.
A University of Michigan study suggests that women, but not men, automatically associate sex with submission and that connection reduces the quality of their sexual experience.
A single dose of an investigational anti-inflammatory drug called inclacumab considerably reduces damage to heart muscle during angioplasty (the opening of a blocked artery), according to a recent international clinical trial spearheaded by Dr. Jean-Claude Tardif, Director of the Research Centre at the Montreal Heart Institute, affiliated with the University of Montreal.
› Verified 3 days ago
Safal Shetty, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 6001 Professional Pkwy Ste 2020, Douglasville, GA 30134 Phone: 770-422-1372 | |
Navinchandra M Ruparelia, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 4904 Timber Ridge Dr, Suite 202a, Douglasville, GA 30135 Phone: 770-949-6548 Fax: 770-949-9561 | |
Dr. Gray Akoegbe, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 6001 Professional Pkwy Ste 2080, Douglasville, GA 30134 Phone: 678-715-5080 | |
Neal K Osborn, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 8855 Hospital Dr, Suite 101, Douglasville, GA 30134 Phone: 678-784-5020 Fax: 678-784-5024 | |
Dr. Kathryn Amanda Mcfarland, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 8687 Hospital Dr Ste 102, Douglasville, GA 30134 Phone: 678-785-5001 Fax: 888-464-0963 | |
Dr. Nana Abena Arthur, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 8954 Hosptial Drive, Wellstar Health System Douglas Hospital, Douglasville, GA 30134 Phone: 678-838-2585 |